Sihuan Pharmaceutical Holdings Group Ltd (SHPHF)
0.0575
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Sihuan Pharmaceutical Holdings Group Total Liabilities (Quarterly): 902.64M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 902.64M |
| June 30, 2023 | 899.34M |
| June 30, 2023 | 899.34M |
| December 31, 2022 | 942.23M |
| June 30, 2022 | 941.47M |
| June 30, 2022 | 941.47M |
| December 31, 2021 | 838.64M |
| June 30, 2021 | 560.88M |
| June 30, 2021 | 560.88M |
| December 31, 2020 | 473.76M |
| June 30, 2020 | 588.96M |
| June 30, 2020 | 588.96M |
| December 31, 2019 | 375.78M |
| June 30, 2019 | 441.36M |
| June 30, 2019 | 441.36M |
| December 31, 2018 | 388.01M |
| June 30, 2018 | 406.15M |
| June 30, 2018 | 406.15M |
| December 31, 2017 | 345.52M |
| Date | Value |
|---|---|
| June 30, 2017 | 415.06M |
| June 30, 2017 | 415.06M |
| December 31, 2016 | 175.16M |
| June 30, 2016 | 251.54M |
| June 30, 2016 | 251.54M |
| December 31, 2015 | 173.95M |
| June 30, 2015 | 243.34M |
| June 30, 2015 | 243.34M |
| December 31, 2014 | 309.03M |
| June 30, 2014 | 274.20M |
| June 30, 2014 | 274.20M |
| December 31, 2013 | 356.44M |
| June 30, 2013 | 305.78M |
| June 30, 2013 | 305.78M |
| December 31, 2012 | 364.03M |
| June 30, 2012 | 285.32M |
| December 31, 2011 | 293.90M |
| June 30, 2011 | 297.14M |
| December 31, 2010 | 36.63M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
375.78M
Minimum
Dec 2019
942.23M
Maximum
Dec 2022
693.14M
Average
588.96M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 51.10M |
| Zai Lab Ltd | 226.27M |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.627B |
| Shareholders Equity (Quarterly) | 625.25M |
| Debt to Equity Ratio | 0.2739 |
| Current Ratio | 1.511 |
| Net Debt Paydown Yield | -0.18% |